1. HomeBaile
  2. Statutory InstrumentsIonstraimí Reachtúla
  3. 2019
  4. S.I. No. 649/2019 - Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) (Amendment) Regulations 2019

S.I. No. 649/2019 - Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) (Amendment) Regulations 2019

Notice of the making of this Statutory Instrument was published in

“Iris Oifigiúil” of 31st December, 2019.

I, SIMON HARRIS, Minister for Health, in exercise of the powers conferred on me by sections 4 and 5 (as amended by section 15 of the Misuse of Drugs Act 1984 (No. 18 of 1984) and section 3 of the Misuse of Drugs (Amendment) Act 2016 (No. 9 of 2016)) of the Misuse of Drugs Act 1977 (No. 12 of 1977), hereby make the following regulations:

1. These Regulations may be cited as the Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) (Amendment) Regulations 2019.

2. The Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) Regulations 2019 ( S.I. No. 262 of 2019 ) are amended by substituting for Schedule 1 the following:

“SCHEDULE 1

Regulation 2

Specified Controlled Drugs

Name of Cannabis product or preparation and brand name

Dosage form

Concentration of THC (percentage, weight/weight or weight/volume)

Name of manufacturer

Aurora High CBD Oil Drops

Oral solution

Less than 3% w/v (< 30mg/ml)

This product also contains cannabidiol (CBD) 60% w/v (600mg/ml)

Aurora Cannabis Enterprises Inc., 4439 Township Road 304,Cremona, Alberta,Canada, T0M 0R0

CannEpil ™

Oral solution

0.5% w/v (5mg/ml)

This product also contains cannabidiol (CBD) 10% w/v (100mg/ml)

MGC Pharmaceuticals d.o.o.,

Kamniška ulica 29, 1000, Ljubljana, Slovenia

Tilray Oral Solution THC10:CBD10 25ml

Oral solution

1% w/v (10mg/ml)

This product also contains cannabidiol (CBD) 1% w/v (10mg/ml)

Tilray Canada Ltd., 1100 Maughan Road, Nanaimo, BC, V9X 1J2, Canada

”.

/images/ls

GIVEN under my Official Seal,

17 December, 2019.

SIMON HARRIS,

Minister for Health.

EXPLANATORY NOTE

(This note is not part of the Instrument and does not purport to be a legal interpretation.)

The purpose of these Regulations is to amend the Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) Regulations 2019 to replace Schedule 1 in order to list certain cannabis products or preparations for medical use as “specified controlled drugs”.

These Regulations may be cited as the Misuse Of Drugs (Prescription And Control Of Supply Of Cannabis For Medical Use) (Amendment) Regulations 2019.